Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| HUSP Clinical Genetics Laboratory, |
RCV001353346 | SCV001548293 | likely pathogenic | Intellectual disability, autosomal dominant 42 | 2020-10-16 | no assertion criteria provided | clinical testing | The c.496T>C variant in GNB1 gene (NM_002074.5) consists of an amino acid change (p.Cys166Arg). The altered nucleotide is located 2 bases away from the site of splicing, so in-silico tools predict that it is very likely to affect conventional splicing. This alteration has not been reported previously in the literature and it is not detected in general population. Pathological variants in the GNB1 gene are associated with the phenotype of Mental retardation, autosomal dominant 42 (OMIM: 616973) with autosomal dominant inheritance, characterized by a developmental delay and intellectual disability. Among the most common phenotypic traits are: epilepsy, general growth deficit (without microcephaly), hypotonia. Most of variants reported in the GNB1 gene are considered pathological. In our case, the variant was detected in a 4-year-old boy with epilepsy and neurological regression. This alteration was not detected in his parents, so it was a de novo variant. Therefore, we consider that clinical significance of c.496T>C variant is likely pathogenic. |